Jaguar Health, Inc. (NASDAQ:JAGX – Get Free Report) saw a significant increase in short interest in September. As of September 30th, there was short interest totalling 413,000 shares, an increase of 11.4% from the September 15th total of 370,700 shares. Based on an average daily volume of 717,100 shares, the days-to-cover ratio is currently 0.6 days. Currently, 5.3% of the shares of the stock are sold short.
Jaguar Health Price Performance
Shares of NASDAQ:JAGX opened at $1.23 on Thursday. The company has a debt-to-equity ratio of 1.32, a current ratio of 2.10 and a quick ratio of 1.60. Jaguar Health has a 1-year low of $0.95 and a 1-year high of $30.86. The business has a 50-day moving average price of $1.17 and a two-hundred day moving average price of $4.68.
Jaguar Health (NASDAQ:JAGX – Get Free Report) last announced its quarterly earnings data on Tuesday, August 13th. The biotechnology company reported ($4.04) EPS for the quarter, missing analysts’ consensus estimates of ($1.20) by ($2.84). Jaguar Health had a negative return on equity of 412.63% and a negative net margin of 350.18%. The company had revenue of $2.72 million for the quarter. On average, equities research analysts expect that Jaguar Health will post -0.78 earnings per share for the current year.
Institutional Investors Weigh In On Jaguar Health
Wall Street Analysts Forecast Growth
Separately, StockNews.com raised Jaguar Health from a “sell” rating to a “hold” rating in a report on Friday, September 13th.
Read Our Latest Report on Jaguar Health
About Jaguar Health
Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.
Recommended Stories
- Five stocks we like better than Jaguar Health
- How to invest in marijuana stocks in 7 steps
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- Why is the Ex-Dividend Date Significant to Investors?
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.